Nippon Boehringer Ingelheim Co., Ltd.

Running trials

• Not yet recruiting

  Real-world Outcome of Zongertinib in Japan (J-HERZ)

  NCT07926308· Source

• Active, not recruiting

  SGLT2 Inhibitors and Renal Anemia in Japan: RWD

  NCT07063316· Source

• Active, not recruiting

  Post Marketing Surveillance of JARDIANCE in Chronic Kidney Disease

  NCT06527846· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Emotional and Social Experiences of Antifibrotic (AF) Therapy Among Idiopathic Pulmonary Fibrosis (IPF)/Progressive Pulmonary Fibrosis (PPF) Patients: A Real-World Study

  NCT07743996· Source

• Completed

  PMS of Spesolimab I.V. in GPP Patients With Acute Symptoms

  NCT05670821· Source

• Completed

  Post Marketing Surveillance (PMS) of JARDIANCE in Chronic Heart Failure (CHF)

  NCT05262764· Source

• Completed

  Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan

  NCT04325217· Source